Clin2
NCT07767175Possibly a fitNot yet recruiting

Weight loss study for adults with overweight or obesity

OverweightObesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This study tests an investigational medication, called NNC0721-8060, to see how it works in people with excess weight (overweight or obesity). It may help with weight loss, but is still in early human testing.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
142 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be between 18 and 55 years old.
  • Your body mass index (BMI) must be between 27.0 and 34.9.
  • You must not have diabetes (an A1c level below 6.5%).
  • You must be in generally good health, as judged by the study doctor.
  • Women who can have children must use birth control and not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07639021Recruiting· Phase 2
Testing Different Dose Schedules of a New Weight Loss Medicine

This study tests a new injectable medication (NNC0662-0419) designed to help people with obesity lose weight. Researchers are comparing different ways of increasing the dose to find the safest and most effective approach.

Montgomery, Alabama
NCT07400107Not yet recruiting· Phase 3
Weight loss study for people with type 2 diabetes

This study tests a new medicine called NNC0487-0111 to see how well it helps people with excess body weight and type 2 diabetes lose weight, compared to another medicine called semaglutide. It may be an option if you have type 2 diabetes and are looking to manage your weight.

Hollywood, Florida
NCT07770841Recruiting· Phase 3
Oral medication for weight loss study

This study tests an oral medicine (semaglutide) to see if it helps adults with excess weight lose weight. It might offer an easier, pill-based treatment option for weight management.

Birmingham, Alabama
NCT07465965Recruiting· Phase 1
Weight loss study of semaglutide nasal spray in overweight or obese adults

This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.

Secaucus, New Jersey
NCT07627074Recruiting
Real-world weight loss study with semaglutide

This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.

Seattle, Washington
NCT06825793Not yet recruiting
Semaglutide for weight loss in obesity

This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.

Hear when a new Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.